메뉴 건너뛰기
Journal of Immunotherapy
Volumn 33, Issue 9, 2010, Pages 1014-1015
14G2a anti-GD2 crossreactivity with the CD166 antigen
Author keywords

[No Author keywords available]
Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CROSS REACTING ANTIGEN; EPITOPE; GANGLIOSIDE GD2; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 2; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; MURINE MONOCLONAL ANTIBODY 14G2A; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;
EID: 78149283472     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3181f3bf36     Document Type: Letter
Times cited : (4)
References (7)
  • 1
    • 77953063005 scopus 로고    scopus 로고
    • Reducing epitope spread during affinity maturation of an anti-Ganglioside GD2 antibody
    • Hu J, Huang X, Chang-Chun L, et al. Reducing epitope spread during affinity maturation of an anti-Ganglioside GD2 antibody. J Immunol. 2009;183:5748-5755.
    • (2009) J. Immunol. , vol.183 , pp. 5748-5755
    • Hu, J.1    Huang, X.2    Chang-Chun, L.3
  • 2
    • 27244448135 scopus 로고    scopus 로고
    • Tumor antigens and tumor antigen discovery
    • Graziano DF, Finn OJ. Tumor antigens and tumor antigen discovery. Cancer Treat Res. 2005;123:89-111.
    • (2005) Cancer Treat Res. , vol.123 , pp. 89-111
    • Graziano, D.F.1    Finn, O.J.2
  • 3
    • 0023165018 scopus 로고
    • Disialoganglioside GD2 on human neuro-blastoma cells: Target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth
    • Mujoo K, Cheresh DA, Yang HM, et al. Disialoganglioside GD2 on human neuro-blastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Cancer Res. 1987;47:6.
    • (1987) Cancer Res. , vol.47 , pp. 6
    • Mujoo, K.1    Cheresh, D.A.2    Yang, H.M.3
  • 4
    • 0035888244 scopus 로고    scopus 로고
    • Targeting of GD2-positive tumor cells by human T-lymphocytes engineered to express chimeric T-cell receptor genes
    • Rossig C, Bollard MC, Nuchtern JG, et al. Targeting of GD2-positive tumor cells by human T-lymphocytes engineered to express chimeric T-cell receptor genes. Intern J Cancer. 2001;94:8.
    • (2001) Intern. J. Cancer , vol.94 , pp. 8
    • Rossig, C.1    Bollard, M.C.2    Nuchtern, J.G.3
  • 5
    • 78149285950 scopus 로고
    • Phase I trial of a murine monoclonal anti-GD2 in metastatic melanoma
    • Sahel M, Khazaeli MB, Wheeler RH, et al. Phase I trial of a murine monoclonal anti-GD2 in metastatic melanoma. Cancer Res. 1992;52:5.
    • (1992) Cancer Res. , vol.52 , pp. 5
    • Sahel, M.1    Khazaeli, M.B.2    Wheeler, R.H.3
  • 6
    • 78149282856 scopus 로고    scopus 로고
    • The development of antibody-IL-2 immu-notherapy with hu14. 18-IL2 in melanoma and neuroblastoma
    • Yamane BH, Hank JA, Albertini MR, et al. The development of antibody-IL-2 immu-notherapy with hu14. 18-IL2 in melanoma and neuroblastoma. Expert Opinion Investigating Drugs. 2009;18:9.
    • (2009) Expert Opinion Investigating Drugs , vol.18 , pp. 9
    • Yamane, B.H.1    Hank, J.A.2    Albertini, M.R.3
  • 7
    • 78149280317 scopus 로고    scopus 로고
    • Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens
    • Kozber D. Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens. Immunologic Res. 2009;10:9.
    • (2009) Immunologic Res. , vol.10 , pp. 9
    • Kozber, D.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.